Phase II Trial of Erlotinib Plus Sirolimus for Patients With Recurrent Malignant Glioma Multiforme
Phase of Trial: Phase II
Latest Information Update: 26 Nov 2014
At a glance
- Drugs Erlotinib (Primary) ; Sirolimus (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 10 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Feb 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 26 May 2008 New trial record.